Pharma’s Pandemic Playbook
Before a single case of COVID-19 was reported, Moderna had already built a fortress of foundational mRNA patents—some filed as early as 2010–2016. When the pandemic hit, these patents translated into blockbuster revenues: racked up $37 billion in 2021 alone, with total COVID-medicine sales expected to exceed $50 billion in 202…
Keep reading with a 7-day free trial
Subscribe to Mr. Holistic to keep reading this post and get 7 days of free access to the full post archives.